A postinfluenza model of Staphylococcus aureus pneumonia

Journal of Infectious Diseases

Volumn 201, Issue 4, 2010, Pages 508-515

  Lee, Mei Ho ^a   Arrecubieta, Carlos ^a,d   Martin, Francis J ^b   Prince, Alice ^b   Borczuk, Alain C ^c   Lowy, Franklin D ^a,c  

^a Division of Infectious Diseases   (United States)

^b Department of Pharmacology ^*  (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d Regan Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; PANTON VALENTINE LEUKOCIDIN; PROTEIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; EXPERIMENTAL MODEL; FEMALE; HISTOPATHOLOGY; INFLUENZA VIRUS; LUNG LAVAGE; LUNG PARENCHYMA; METASTASIS; MORBIDITY; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS;

ANALYSIS OF VARIANCE; ANIMALS; BACTERIAL TOXINS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXOTOXINS; FEMALE; FLOW CYTOMETRY; HEMOLYSIN PROTEINS; HISTOCYTOCHEMISTRY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INTERFERON-GAMMA; LEUKOCIDINS; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA, STAPHYLOCOCCAL; STAPHYLOCOCCAL PROTEIN A; STAPHYLOCOCCUS AUREUS; STATISTICS, NONPARAMETRIC;

EID: 75749114481     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/650204     Document Type: Article

References (36)

1. Chambers HF. The changing epidemiology of Staphylococcus aureus. Emerg Infect Dis 2001;7:178-182.
2. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no iden-tified predisposing risk. JAMA 1998; 279:593-598.
3. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a pub-lic-health threat. Lancet 2006; 368:874-885.
4. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukoddin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29:1128-1132.
5. Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphy-lococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005;40:100-107.
6. Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-2004 influenza season. Emerg Infect Dis 2006; 12:894-899.
7. Kallen AJ, Hageman J, Gorwitz R, Beekmann SE, Polgreen PM. Char-acteristics of Staphylococcus aureus community-acquired pneumonia during the 2006-2007 influenza season. Clin Infect Dis 2007; 45:1655.
8. Brundage JF. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 2006;6:303-312.
9. Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 1918-1919 influenza pandemic. Emerg Infect Dis 2008; 14:1193-1199.
10. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962-970.
11. Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mor-tality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008; 122:805-811.
12. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae, characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002; 186:341-350.
13. 13. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006; 19:571-582. (Pubitemid 44134311)
14. Shahangian A, Chow EK, Tian X, et al. Type I IFNs mediate devel-opment of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009;119:1910-1920.
15. Gaush CR, Smith TF. Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl Microbiol 1968; 16: 588-594.
16. 16. Garcia-Sastre A, Egorov A, Matassov D, et al. Influenza A virus lacking the NSl gene replicates in interferon-defident systems. Virology 1998; 252:324-330. (Pubitemid 29013414)
17. Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-assodated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194:1761-1770.
18. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis 2003; 187:1000-1009.
19. -△utri;c method. Methods 2001; 25: 402-408.
20. Morens DM, Fauci AS. The 1918 influenza pandemic: insights for the 21st century. J Infect Dis 2007; 195:1018-1028.
21. Outbreak of swine-origin influenza A (HlNl) virus infection: Mexico, March-April 2009. MMWR Morb Mortal WkIy Rep 2009; 58:467-470.
22. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007;315:1130-1133.
23. Wardenburg JB, Patel RJ, Schneewind O. Surface proteins and exo-toxins are required for the pathogenesis of Staphylococcus aureus pneu-monia. Infect Immun 2007;75:1040-1044.
24. Montgomery CP, Boyle-Vavra S, Adem PV, et al. Comparison of vir-ulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis 2008; 198:561-570.
25. Montgomery CP, Daum RS. Transcription of inflammatory genes in the lung after infection with community-assodated methicillin-resis-tant Staphylococcus aureus: a role for Panton-Valentine leukocidin? In-fect Immun 2009;77:2159-2167.
26. Wardenburg JB, Bae T, Otto M, DeLeo FR, Schneewind O. Poring over pores: alpha-hemolysin and Panton-Valentine leukoddin in Staphylo-coccus aureus pneumonia. Nat Med 2007; 13:1405-1406.
27. Diep BA, Palazzolo-Ballance AM, Tattevin P, et al. Contribution of Panton-Valentine leukocidin in community-associated methicillin-re-sistant Staphylococcus aureus pathogenesis. PLoS ONE 2008; 3:e3198.
28. Hers JF, Masurel N, Mulder J. Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza. Lancet 1958; 2: 1141-1143.
29. McLoughlin RM, Lee JC, Kasper DL, Tzianabos AO. IFN-gamma reg-ulated chemokine production determines the outcome of Staphylo-coccus aureus infection. J Immunol 2008; 181:1323-1332.
30. Muralimohan G, Rossi RJ, Guernsey LA, Thrall RS, Vella AT. Inhalation of Staphylococcus aureus enterotoxin A induces IFN-gamma and CD8 T cell-dependent airway and interstitial lung pathology in mice. J Im-munol 2008; 181:3698-3705.
31. Shornick LP, Wells AG, Zhang Y, et al. Airway epithelial versus immune cell Statl function for innate defense against respiratory viral infection. J Immunol 2008; 180:3319-3328.
32. 32. Geiss GK, Salvatore M, Tumpey TM, et al. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NSl protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A 2002;99:10736-10741. (Pubitemid 34907046)
33. 33. Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 2008; 14:558-564. (Pubitemid 351655219)
34. Martin FJ, Gomez MI, Wetzel DM, et al. Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J Clin Invest 2009; 119:1931-1939.
35. 35. Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. MoI Microbiol 2003;48:1429-1449. (Pubitemid 36751052)
36. Szmigielski S, Prevost G, Monteil H, Colin DA, Jeljaszewicz J. Leu-kocidal toxins of staphylococci. Zentralbl Bakteriol 1999;289:185-201.